Abstract

Background: The left atrial appendage (LAA) is a major source of thrombus and non-chicken wing (CW). LAA morphology is a risk factor for embolic events in atrial fibrillation. However, the association of non-CW morphology with embolic stroke recurrence is unknown in patients with embolic stroke of undetermined source (ESUS) and atrial cardiopathy.Methods: We conducted retrospective analyses using a prospective institutional stroke registry (2013–2017). Patients with ESUS and atrial cardiopathy were enrolled. Atrial cardiopathy was diagnosed if an increased left atrial diameter (>40 mm, men; >38 mm, women), supraventricular tachycardia, or LAA filling defect on computed tomography (CT) were present. Patients admitted >24 h after onset were excluded. LAA morphology was evaluated using CT and categorized into CW vs. non-CW types. The primary outcome was embolic stroke recurrence. Multivariable Cox proportional hazards models were used to examine the independent association between LAA morphology and outcome.Results: Of 157 patients, 81 (51.6%) had CW LAA morphology. The median follow-up was 41.5 (interquartile range 12.3–58.5) months corresponding to 509.8 patient years. In total, 18 participants experienced embolic stroke recurrences (3.80 per 100 patient-years). Non-CW morphology was more associated with embolic stroke recurrence than CW morphology (hazard ratio (HR), 3.17; 95% confidence interval (CI), 1.13–8.91; p = 0.029). After adjusting for CHA2DS2-VASc score and number of potential embolic sources, non-CW morphology showed an independent association with outcome (adjusted HR, 2.90; 95% CI, 1.02–8.23; p = 0.045).Conclusions: The LAA morphology types may help identify high risk of embolic stroke recurrence in ESUS with atrial cardiopathy. LAA morphology in atrial cardiopathy may provide clues for developing therapies tailored to specific mechanisms.

Highlights

  • The concept of embolic stroke of undetermined source (ESUS) assumed that most cryptogenic strokes are thromboembolic and could benefit from anticoagulation [1]

  • The inclusion criteria for this study are as follows: [1] admission to Kyungpook National University Hospital from April 2013 to December 2017, [2] ESUS defined by the Cryptogenic Stroke/ESUS International Working Group [1], and [3] atrial cardiopathy. This is defined as the increased left atrial diameter (>40 mm for men and >38 mm for women), supraventricular tachycardia/subclinical atrial fibrillation (AF), or an left atrial appendage (LAA) filling defect on cerebral computed tomography angiography (CCTA) [19,20,21,22,23]

  • The present study showed that the prevalence of individual LAA morphology types in ESUS and atrial cardiopathy were 51.6% chicken wing (CW) and 48.4% non-CW

Read more

Summary

Introduction

The concept of embolic stroke of undetermined source (ESUS) assumed that most cryptogenic strokes are thromboembolic and could benefit from anticoagulation [1]. One of the subgroups of ESUS is atrial cardiopathy, which leaves atrial substrates with structural, functional, or electrical remodeling preceding clinical atrial fibrillation (AF) [4]. Several markers of atrial cardiopathy are associated with subsequent stroke events [10, 11]. The left atrial appendage (LAA) is a major source of thrombus and non-chicken wing (CW). LAA morphology is a risk factor for embolic events in atrial fibrillation. The association of non-CW morphology with embolic stroke recurrence is unknown in patients with embolic stroke of undetermined source (ESUS) and atrial cardiopathy

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call